293 related articles for article (PubMed ID: 14764527)
41. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes.
De Castro LM; Jonassaint JC; Graham FL; Ashley-Koch A; Telen MJ
Am J Hematol; 2008 Jan; 83(1):19-25. PubMed ID: 17724699
[TBL] [Abstract][Full Text] [Related]
42. Impact of sickle cell disease on presentation and progression of paediatric HIV: a retrospective cohort study.
Ssenyondwa J; George PE; Carlos Bazo-Alvarez J; Mercedes R; Kanywa JB; Naturinda E; Wasswa PLM; Lubega J
Trop Med Int Health; 2020 Jul; 25(7):897-904. PubMed ID: 32329120
[TBL] [Abstract][Full Text] [Related]
43. East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients.
Karacaoglu PK; Asma S; Korur A; Solmaz S; Buyukkurt NT; Gereklioglu C; Kasar M; Ozbalcı D; Unal S; Kaya H; Gurkan E; Yeral M; Sariturk Ç; Boga C; Ozdogu H
Ann Hematol; 2016 May; 95(6):993-1000. PubMed ID: 27068408
[TBL] [Abstract][Full Text] [Related]
44. Newborn screening for sickle cell disease: effect on mortality.
Vichinsky E; Hurst D; Earles A; Kleman K; Lubin B
Pediatrics; 1988 Jun; 81(6):749-55. PubMed ID: 3368274
[TBL] [Abstract][Full Text] [Related]
45. Mortality and Causes of Death From Sickle Cell Disease in The Netherlands, 1985-2017.
Rettenbacher E; Zaal J; Heijboer H; van der Plas EM; Hof M; Biemond BJ; Fijnvandraat K;
J Pediatr Hematol Oncol; 2021 Oct; 43(7):258-265. PubMed ID: 34001787
[TBL] [Abstract][Full Text] [Related]
46. Doppler assessment of renal hemodynamic alterations in homozygous sickle cell disease and sickle Beta-thalassemia.
Saif A; Soliman N; Abdelhamid A
Ultrason Imaging; 2015 Jul; 37(3):258-64. PubMed ID: 25294847
[TBL] [Abstract][Full Text] [Related]
47. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
[TBL] [Abstract][Full Text] [Related]
48. Psychosocial aspects of sickle cell disease (SCD) in childhood and adolescence: a review.
Midence K; Fuggle P; Davies SC
Br J Clin Psychol; 1993 Sep; 32(3):271-80. PubMed ID: 8251957
[TBL] [Abstract][Full Text] [Related]
49. Impact of genotype on clinical course in sickle cell disease and the utility of neutrophil-lymphocyte ratio: a ten-year single-institution experience.
Mathavan A; Mathavan A; Mathavan M; Krekora U; Winer AJ; Altshuler E; Wnek R; Hones K; Thaper A; Artola R; Pucci L; Haley P; Carter D; Snead W; Manfrini D; Leach DF; DeLaune JD; Mandernach MW
Expert Rev Hematol; 2023; 16(9):701-710. PubMed ID: 37395002
[TBL] [Abstract][Full Text] [Related]
50. The excess burden of stroke in hospitalized adults with sickle cell disease.
Strouse JJ; Jordan LC; Lanzkron S; Casella JF
Am J Hematol; 2009 Sep; 84(9):548-52. PubMed ID: 19623672
[TBL] [Abstract][Full Text] [Related]
51. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
52. Clinical events in a large prospective cohort of children with sickle cell disease in Nagpur, India: evidence against a milder clinical phenotype in India.
Jain D; Arjunan A; Sarathi V; Jain H; Bhandarwar A; Vuga M; Krishnamurti L
Pediatr Blood Cancer; 2016 Oct; 63(10):1814-21. PubMed ID: 27279568
[TBL] [Abstract][Full Text] [Related]
53. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment.
Lê PQ; Gulbis B; Dedeken L; Dupont S; Vanderfaeillie A; Heijmans C; Huybrechts S; Devalck C; Efira A; Dresse MF; Rozen L; Benghiat FS; Ferster A
Pediatr Blood Cancer; 2015 Nov; 62(11):1956-61. PubMed ID: 26173735
[TBL] [Abstract][Full Text] [Related]
54. Hospitalisations for sickle-cell disease in an Australian paediatric population.
Teoh Y; Greenway A; Savoia H; Monagle P; Roy J; Barnes C
J Paediatr Child Health; 2013 Jan; 49(1):68-71. PubMed ID: 23198729
[TBL] [Abstract][Full Text] [Related]
55. Sickle cell disease: the Lebanese experience.
Inati A; Jradi O; Tarabay H; Moallem H; Rachkidi Y; El Accaoui R; Isma'eel H; Wehbe R; Mfarrej BG; Dabbous I; Taher A
Int J Lab Hematol; 2007 Dec; 29(6):399-408. PubMed ID: 17988293
[TBL] [Abstract][Full Text] [Related]
56. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
57. Sickle cell/β-thalassemia: Comparison of Sβ
Benites BD; Bastos SO; Baldanzi G; Dos Santos AO; Ramos CD; Costa FF; Gilli SC; Saad ST
Hematology; 2016 Dec; 21(10):623-629. PubMed ID: 27237196
[TBL] [Abstract][Full Text] [Related]
58. Clinical correlates of steady-state oxyhaemoglobin desaturation in children who have sickle cell disease.
Quinn CT; Ahmad N
Br J Haematol; 2005 Oct; 131(1):129-34. PubMed ID: 16173973
[TBL] [Abstract][Full Text] [Related]
59. Sickle cell disease in Africa: a neglected cause of early childhood mortality.
Grosse SD; Odame I; Atrash HK; Amendah DD; Piel FB; Williams TN
Am J Prev Med; 2011 Dec; 41(6 Suppl 4):S398-405. PubMed ID: 22099364
[TBL] [Abstract][Full Text] [Related]
60. [Screening of cerebral vasculopathy in sickle cell anemia children using transcranial Doppler].
Dorie A; Guindo A; Saro YS; Touré BA; Fané B; Dembelé AK; Diallo DA
Arch Pediatr; 2015 Mar; 22(3):260-6. PubMed ID: 25636211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
